K241847

Substantially Equivalent

Imbio PHA (4.0.0)

Applicant: Imbio, Inc.
Product code: QIH
Advisory panel: Radiology
Date received: 2024-06-26
Decision date: 2024-08-30
Decision: Substantially Equivalent
Clearance type: Special
Location: Minneapolis, MN, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.